{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:12:38Z","timestamp":1787062358468,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"crossref","award":["7-21-PDF-022"],"award-info":[{"award-number":["7-21-PDF-022"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["R01EYE26080-01"],"award-info":[{"award-number":["R01EYE26080-01"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100017618","name":"Division of Diabetes, Endocrinology, and Metabolic Diseases","doi-asserted-by":"crossref","award":["DP3- DK-094333-01"],"award-info":[{"award-number":["DP3- DK-094333-01"]}],"id":[{"id":"10.13039\/100017618","id-type":"DOI","asserted-by":"crossref"}]},{"name":"JDRF","award":["17-2013-310"],"award-info":[{"award-number":["17-2013-310"]}]},{"name":"Dianne Nunnally Hoppes Fund"},{"name":"Beatson Pledge Fund"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate Retinol-Binding Protein 3 (RBP3) from photoreceptors in aqueous and its association with vitreous concentrations, diabetic retinopathy (DR) severity, retinal layer thickness, and clinical characteristics in people with diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>RBP3 concentration was measured by custom-developed enzyme-linked immunosorbent assay in aqueous and correlated with vitreous concentrations in patients from the 50-Year Medalist study and Beetham Eye Institute at Joslin Diabetes Center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Aqueous RBP3 concentration (N = 131) was elevated in eyes with no to mild DR (mean \u00b1 SD 0.7 nM \u00b1 0.2) and decreased in eyes with moderate to severe DR (0.65 nM \u00b1 0.3) and proliferative DR (0.5 nM \u00b1 0.2,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) compared to eyes without diabetes. Aqueous and vitreous RBP3 concentrations correlated with each other (r = 0.34,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001) and between fellow eyes (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001). History of retinal surgery did not affect aqueous RBP3 concentrations, but cataract surgery affected both vitreous and aqueous levels. Elevated aqueous RBP3 concentration associated with increased thickness of the outer nuclear layer (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.004) and correlated with hemoglobin A1c, whereas vitreous RBP3 concentrations correlated with diabetic systemic complications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These findings suggest that aqueous RBP3 concentration may be an important endogenous clinical retinal protective factor, a biomarker for DR severity, and a promising VEGF-independent clinical intervention target in DR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004059","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T12:00:41Z","timestamp":1716206441000},"page":"1026-1033","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["CLINICAL CHARACTERIZATION OF AQUEOUS AND VITREOUS RETINOL-BINDING PROTEIN 3 CONCENTRATIONS IN RELATION TO DIABETIC RETINOPATHY SEVERITY, RETINAL STRUCTURES, AND SYSTEMIC COMPLICATIONS"],"prefix":"10.1097","volume":"44","author":[{"given":"Ward","family":"Fickweiler","sequence":"first","affiliation":[{"name":"Research Division, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Joslin Diabetes Center, Boston, Massachusetts;"},{"name":"Beetham Eye Institute, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Joslin Diabetes Center, Boston, Massachusetts;"},{"name":"Department of Ophthalmology, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-8685","authenticated-orcid":false,"given":"Tanvi","family":"Chokshi","sequence":"additional","affiliation":[{"name":"Research Division, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Joslin Diabetes Center, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya","family":"Jangolla","sequence":"additional","affiliation":[{"name":"Research Division, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Joslin Diabetes Center, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margalit","family":"Mitzner","sequence":"additional","affiliation":[{"name":"Research Division, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Joslin Diabetes Center, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Hsien","family":"Wu","sequence":"additional","affiliation":[{"name":"Research Division, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Joslin Diabetes Center, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunseok","family":"Park","sequence":"additional","affiliation":[{"name":"Research Division, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Joslin Diabetes Center, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoungmin","family":"Park","sequence":"additional","affiliation":[{"name":"Research Division, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Joslin Diabetes Center, Boston, Massachusetts;"},{"name":"Department of Medicine, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd Paul","family":"Aiello","sequence":"additional","affiliation":[{"name":"Research Division, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Joslin Diabetes Center, Boston, Massachusetts;"},{"name":"Beetham Eye Institute, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Joslin Diabetes Center, Boston, Massachusetts;"},{"name":"Department of Ophthalmology, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Sun","sequence":"additional","affiliation":[{"name":"Research Division, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Joslin Diabetes Center, Boston, Massachusetts;"},{"name":"Beetham Eye Institute, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Joslin Diabetes Center, Boston, Massachusetts;"},{"name":"Department of Ophthalmology, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"King","sequence":"additional","affiliation":[{"name":"Research Division, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Joslin Diabetes Center, Boston, Massachusetts;"},{"name":"Department of Ophthalmology, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Harvard Medical School, Boston, Massachusetts; and"},{"name":"Department of Medicine, Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"s84","DOI":"10.2337\/diacare.27.2007.S84","article-title":"Retinopathy in diabetes","volume":"27","author":"Fong","year":"2004","journal-title":"Diabetes Care"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","article-title":"Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema","volume":"117","author":"Elman","year":"2010","journal-title":"Ophthalmology"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0161-6420(81)34978-1","article-title":"Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of diabetic retinopathy study (DRS) findings, DRS report number 8","volume":"88","author":"Riaskoff","year":"1981","journal-title":"Ophthalmology"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2019.5790","article-title":"Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the center of the macula and good visual acuity: a randomized clinical trial","volume":"321","author":"Baker","year":"2019","journal-title":"JAMA"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2337\/dc10-1675","article-title":"Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the Joslin 50-year medalist study","volume":"34","author":"Sun","year":"2011","journal-title":"Diabetes Care"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"eaau6627","DOI":"10.1126\/scitranslmed.aau6627","article-title":"Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy","volume":"11","author":"Yokomizo","year":"2019","journal-title":"Sci Transl Med"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2337\/dc22-0165","article-title":"Elevated retinol binding protein 3 concentrations are associated with decreased vitreous inflammatory cytokines, VEGF, and progression of diabetic retinopathy","volume":"45","author":"Fickweiler","year":"2022","journal-title":"Diabetes Care"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2337\/dc17-2250","article-title":"Differential association of microvascular attributions with cardiovascular disease in patients with long duration of type 1 diabetes","volume":"41","author":"Gordin","year":"2018","journal-title":"Diabetes Care"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1007\/s00125-009-1548-8","article-title":"Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy","volume":"52","author":"Garcia-Ram\u00edrez","year":"2009","journal-title":"Diabetologia"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/bjo.81.11.976","article-title":"Diagnostic anterior chamber paracentesis in uveitis: a safe procedure?","volume":"81","author":"Van Der Lelij","year":"1997","journal-title":"The Br J Ophthalmol"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/bjo.2003.027219","article-title":"The safety of anterior chamber paracentesis in patients with uveitis","volume":"88","author":"Cheung","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1167\/iovs.61.2.26","article-title":"Correlation of aqueous, vitreous, and plasma cytokine levels in patients with proliferative diabetic retinopathy","volume":"61","author":"Wu","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/08820538.2022.2078165","article-title":"Liquid biopsy in Retinoblastoma: a review","volume":"37","author":"Ghose","year":"2022","journal-title":"Semin Ophthalmol"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"e0178230","DOI":"10.1371\/journal.pone.0178230","article-title":"Association between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy","volume":"12","author":"Takeuchi","year":"2017","journal-title":"PLoS One"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"659977","DOI":"10.3389\/fphys.2021.659977","article-title":"Biological functions of RBP4 and its relevance for human diseases","volume":"12","author":"Steinhoff","year":"2021","journal-title":"Front Physiol"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0002-9394(14)71914-2","article-title":"The effect of timolol on the concentrations of albumin and IgG in the aqueous humor of the human eye","volume":"96","author":"Stur","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"e1139","DOI":"10.1210\/clinem\/dgaa921","article-title":"Association of cognitive function and retinal neural and vascular structure in type 1 diabetes","volume":"106","author":"Fickweiler","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1167\/iovs.08-2497","article-title":"A homozygous missense mutation in the IRBP gene (RBP3) associated with autosomal recessive retinitis pigmentosa","volume":"50","author":"den Hollander","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1167\/iovs.15-16520","article-title":"Lack of interphotoreceptor retinoid binding protein caused by homozygous mutation of RBP3 is associated with high myopia and retinal dystrophy","volume":"56","author":"Arno","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T13:02:38Z","timestamp":1749128558000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004059","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}